Neutrophils in Bronchoalveolar Lavage Fluid Indicating the Severity and Relapse of Pulmonary Sarcoidosis

被引:4
|
作者
Feng, Haoshen [1 ]
Yan, Lili [2 ]
Zhao, Yabin [3 ]
Li, Zhenhua [3 ]
Kang, Jian [3 ]
机构
[1] China Med Univ, Dept Pulm & Crit Care Med, Shengjing Hosp, Shenyang, Peoples R China
[2] Jinzhou Med Univ, Dept Pulm & Crit Care Med, Affiliated Hosp 1, Jinzhou, Peoples R China
[3] China Med Univ, Inst Resp Dis, Dept Pulm & Crit Care Med, Affiliated Hosp 1, Shenyang, Peoples R China
基金
国家重点研发计划;
关键词
pulmonary sarcoidosis; neutrophils; bronchoalveolar lavage fluid; severity; relapse; MATRIX METALLOPROTEINASES; SEVERE ASTHMA; CELLS; TARGETS;
D O I
10.3389/fmed.2021.787681
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundPulmonary sarcoidosis is a highly heterogeneous granulomatous disease without any specific symptoms and manifestations. Neutrophils in bronchoalveolar lavage fluid (BALF) have been proposed to indicate the severity and prognosis of pulmonary sarcoidosis, but this needs confirmation in patients from different populations due to the heterogeneity of the disease. This study aimed to determine the characteristics of patients with pulmonary sarcoidosis in northeastern China and to explore the relationship between neutrophils in BALF and the severity of pulmonary sarcoidosis. MethodsWe enrolled 432 patients who were diagnosed with pulmonary sarcoidosis in this retrospective study. The symptoms, extrapulmonary involvement, forced vital capacity percentage predicted (FVC % pred), and diffusing capacity of the lung for carbon monoxide percentage predicted (DLco % pred) were recorded. BAL was performed in 319 patients, and the results of a cellular examination of BALF were collected. A total of 123 patients who received corticosteroid treatment were followed up for at least 12 months, and the outcomes were recorded. ResultsCough was the most common symptom, and cutaneous involvement was the most common extrapulmonary manifestation in 304 (70.4%) and 82 (19.0%) patients, respectively. The percentages of patients with high neutrophil counts in BALF (>3%) were higher at Stages 2 and 3 compared with Stages 0 and 1 (33.2 vs. 19.4%, p = 0.007), although the percentages of neutrophils in BALF showed no difference between patients at Stages 0, 1, 2, and 3. Patients with high neutrophil counts in BALF had lower FVC % pred compared with the other patients (79.5 +/- 18.2 vs. 84.9 +/- 14.5%, p = 0.025) and were prone to relapse after corticosteroids were tapered. High neutrophil counts in BALF were independently associated with relapse after corticosteroids were tapered in a binary logistic regression analysis (p = 0.027). ConclusionsPatients with pulmonary sarcoidosis lacked specific symptoms and manifestations. The neutrophil count in BALF could indicate the severity and outcomes of pulmonary sarcoidosis.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] BRONCHOALVEOLAR LAVAGE IN SARCOIDOSIS
    GUPTA, R
    CATCHATOURIAN, R
    BECK, C
    SICILIAN, L
    SZIDON, JP
    CLINICAL RESEARCH, 1978, 26 (05): : A724 - A724
  • [42] High IL-12 levels of bronchoalveolar lavage fluid in advanced pulmonary sarcoidosis.
    Nagano, Y
    Kondo, M
    Tamaoki, J
    Nagal, A
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A340 - A340
  • [43] PROTEIN LEAK IN PULMONARY SARCOIDOSIS - ASSESSMENT OF BRONCHOALVEOLAR LAVAGE FLUID AND PLASMA-ALBUMIN AND FIBRONECTIN
    ROSSMAN, MD
    MCDONALD, JA
    BROEKELMANN, T
    DAUBER, JH
    DANIELE, RP
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1983, 127 (04): : 90 - 90
  • [44] Comparison of induced sputum and bronchoalveolar lavage fluid cell profile during the treatment of pulmonary sarcoidosis
    Mroz, R. M.
    Korniluk, M.
    Stasiak-Barmuta, A.
    Chyczewska, E.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2007, 58 : 445 - 452
  • [45] sTREM-1 in bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis, effect of smoking and inflammation
    Suchankova, M.
    Bucova, M.
    Tibenska, E.
    Demian, J.
    Majer, I
    Novosadova, H.
    Tedlova, E.
    Durmanova, V
    Paulovicova, E.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2013, 114 (12): : 702 - 707
  • [46] BRONCHOALVEOLAR LAVAGE FLUID IN CRYPTOGENIC PULMONARY EOSINOPHILIA
    TURTON, CWG
    LINEHAN, J
    CHIPPENDALE, K
    THORAX, 1984, 39 (09) : 708 - 708
  • [47] Apoptosis resistant bronchoalveolar lavage (BAL) fluid lymphocytes in sarcoidosis
    Stridh, H
    Planck, A
    Gigliotti, D
    Eklund, A
    Grunewald, J
    THORAX, 2002, 57 (10) : 897 - 901
  • [48] PROSTAGLANDINS AND THROMBOXANES IN THE BRONCHOALVEOLAR LAVAGE FLUID - POSSIBLE IMMUNOREGULATION IN SARCOIDOSIS
    BAUGHMAN, RP
    GALLON, LS
    BARCELLI, U
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1984, 130 (05): : 933 - 936
  • [49] PROSTAGLANDINS IN THE BRONCHOALVEOLAR LAVAGE FLUID - POSSIBLE BLOCK OF IMMUNOREGULATION IN SARCOIDOSIS
    BAUGHMAN, RP
    GALLON, LS
    BARCELLI, U
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1986, 465 : 41 - 45
  • [50] Concentration of sFas in bronchoalveolar lavage fluid of smoking patients with sarcoidosis
    Urbankowski, Tomasz
    Safianowska, Aleksandra
    Krenke, Rafal
    Knyziak-Medrzycka, Izabela
    Domagala-Kulawik, Joanna
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40